Skip to Main Content

Paper Details

Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19.
Diabetes Care
13
2022
COVID-19, DKA, Diabetic Ketoacidosis, People, SGLT2, SGLT2i, SGLT2is, T2D, Type 2 Diabetes, diabetes, diabetic ketoacidosis, insulin, men, people, type 2 diabetes
Author NameAffiliation
Jim DaviesOxford National Institute for Health Research Biomedical Research Centre
Jim DaviesUniversity of Oxford
Mikhail KosiborodSaint Luke's Mid America Heart Institute
Mikhail KosiborodUniversity of Missouri
Sarah H WildUsher Institute, University of Edinburgh
  • 1 - 5

Datasets

Release 1.2